From: Impact of bilateral biopsy-detected prostate cancer on an active surveillance population
Variables | n (%) | Median (IQR) |
---|---|---|
Follow-up (m) | 130 | 42.5 (24–74) |
Age (years) | 130 | 61 (57–66) |
< 50 y | 5 (4) | 48 |
50–60 y | 56 (43) | 57 |
> 60 y | 69 (53) | 66 |
PSA (ng/ml) | 130 | 5.08 (4.2–7) |
< 4 ng/ml | 26 (20) | 3.2 l |
≥ 4 ng/ml | 104 (80) | 5.9 |
PSA density | 130 | 0.13 (0.09–0.16) |
≤ 0.15 | 112 (86) | 0.12 |
BMI (kg/m2) | 130 | 27.5 (25.6–31.7) |
≤ 30 | 89 (68.5) | 26.2 |
> 30 | 41 (31.5) | 32.8 |
Prostate Volume (cc) | 130 | 42 (32–57) |
< 30 | 23 (17.7) | 24 |
30–60 | 82 (63.1) | 42 |
> 60 | 25 (19.2) | 73 |
Follow-up biopsies | 130 | 2.5 (2–4) |
2 | 65 (50) | 2 |
3 | 29 (22.3) | 3 |
> 4 | 36 (27.7) | 4.5 |
Max Core Involvement %a | 130 | 5 (3–10) |